Literature DB >> 30819332

Long-term Outcomes of Adolescent Anorexia Nervosa on Bone.

Jessica Mumford1, Michael Kohn2, Julie Briody3, Jane Miskovic-Wheatley4, Sloane Madden4, Simon Clarke5, Andrew Biggin6, Aaron Schindeler7, Craig Munns8.   

Abstract

PURPOSE: Anorexia nervosa (AN) is a chronic and life-threatening eating disorder that can have a considerable negative impact on the growing skeleton. We hypothesized that the long-term impact on bone health may persist even after normalization of body weight.
METHODS: 41 females (mean age 21.2 ± 2.9 years) with a history of adolescent-onset AN attended a follow-up bone health assessment at 5 years (T5, n = 28) or 10 years (T10, n = 13) after their first AN-related hospital admission. Assessment included dual-energy x-ray absorptiometry measurements of the total body, lumbar spine, and proximal femur, peripheral quantitative computed tomography at the radius and tibia, anthropometric measurements, serum biochemistry, fracture history, and a patient questionnaire.
RESULTS: A recovery in body weight and BMI was seen for both the T5 and T10 cohorts (BMI at intake 16.6, BMI at T5-T10 21.2-21.3). Dual-energy x-ray absorptiometry body composition indicated a recovery of fat mass and lean tissue mass. Total BMD was unaffected, but reductions were seen at the femoral neck and arms. Peripheral quantitative computed tomography showed reduced trabecular and cortical bone in the radius, and cortical thinning in the tibia. AN patients showed a statistically significant reduction in measures of radiographic bone health at follow up, although not to a degree that necessitated clinical intervention. Serum insulin-like growth factor 1 was also positively correlated with total BMD and BMC measures. While fracture risk was not increased, a subset of participants (8%) showed multiple (>4) fractures.
CONCLUSION: A longitudinal study of adolescent AN showed persisting negative effects on bone health. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anorexia nervosa; Bone; Bone density; Bone mineral density; Bone morphology; DXA; Dual-energy x-ray absorptiometry; Peripheral quantitative computed tomography; pQCT

Mesh:

Year:  2018        PMID: 30819332     DOI: 10.1016/j.jadohealth.2018.07.025

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  6 in total

Review 1.  [Fractures and bone mineral density in childhood].

Authors:  Christine Hofmann; Herrmann Girschick; Constantin Lapa; Oliver Semler; Franz Jakob
Journal:  Z Rheumatol       Date:  2019-09       Impact factor: 1.372

2.  The absence of association between anorexia nervosa and smoking: converging evidence across two studies.

Authors:  E Caitlin Lloyd; Zoe E Reed; Robyn E Wootton
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-12-22       Impact factor: 4.785

3.  Earlier diagnosis in anorexia nervosa: better watch growth charts!

Authors:  Morgane Marion; Sylvie Lacroix; Marylène Caquard; Laurence Dreno; Pauline Scherdel; Christèle Gras Le Guen; Emmanuelle Caldagues; Elise Launay
Journal:  J Eat Disord       Date:  2020-09-03

Review 4.  Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature.

Authors:  Ashlea Hambleton; Genevieve Pepin; Anvi Le; Danielle Maloney; Stephen Touyz; Sarah Maguire
Journal:  J Eat Disord       Date:  2022-09-05

5.  Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa.

Authors:  Vibha Singhal; Amita Bose; Meghan Slattery; Melanie S Haines; Mark A Goldstein; Nupur Gupta; Kathryn S Brigham; Seda Ebrahimi; Kristin N Javaras; Mary L Bouxsein; Kamryn T Eddy; Karen K Miller; David Schoenfeld; Anne Klibanski; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

6.  Osteoporosis recovery in severe anorexia nervosa: a case report.

Authors:  Pratibha Anand; Philip S Mehler
Journal:  J Eat Disord       Date:  2019-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.